Table 1.
Demographic and clinical data of the study and control groups
| Study group (n=202)
|
Control group (n=149)
|
χ2 | P-value | |||
|---|---|---|---|---|---|---|
| n | % | n | % | |||
| Smoking (n) | 40 | 19.8 | 24 | 16.1 | 0.79 | 0.404 |
| Increased fasting glucose level | 33 | 16.3 | 14 | 9.4 | 3.56 | 0.080 |
| Increased total cholesterol | 16 | 7.9 | 18 | 12.1 | 1.70 | 0.206 |
| Increased triglyceride | 108 | 53.5 | 61 | 40.9 | 5.39 | 0.023 |
| Increased ALT | 42 | 20.8 | 27 | 18.1 | 0.39 | 0.588 |
| Increased AST | 25 | 12.4 | 11 | 7.4 | 2.32 | 0.155 |
|
|
|
|
||||
| Mean | SD | Mean | SD | T | P-value | |
|
|
|
|
||||
| Age (years) | 30.5 | 3.9 | 30.7 | 3.6 | −0.56 | 0.574 |
| BMI | 23.0 | 3.5 | 23.2 | 3.1 | −0.50 | 0.615 |
| Systolic blood pressure | 126.7 | 9.5 | 124.9 | 8.1 | 1.84 | 0.067 |
| Diastolic blood pressure | 73.7 | 6.4 | 72.5 | 5.4 | 1.87 | 0.062 |
| Fasting glucose level (mmol/L) | 5.0 | 1.2 | 5.1 | 1.2 | 1.11 | 0.267 |
| Total cholesterol (mmol/L) | 5.0 | 1.2 | 5.1 | 1.2 | −0.53 | 0.594 |
| Triglyceride (mmol/L) | 2.3 | 1.6 | 2.0 | 1.6 | 2.13 | 0.034 |
| ALT (u/L) | 38.7 | 23.0 | 38.2 | 23.1 | 0.19 | 0.852 |
| AST (u/L) | 27.6 | 12.4 | 26.6 | 10.7 | 0.81 | 0.418 |
| ALP (u/L) | 64.4 | 16.5 | 62.2 | 14.4 | 1.29 | 0.199 |
| GGT (u/L) | 49.8 | 29.5 | 47.4 | 36.8 | 0.69 | 0.493 |
Abbreviations: ALT, alanine aminotransferase; ALP, alkaline phosphatase; AST, aspartate aminotransferase; BMI, body mass index; GGT, gamma-glutamyltransferase.